What's New
Consent to distribute pholcodine-containing medicines will be revoked on 12 January 2024
Following Medsafe's review of pholcodine-containing medicines and on advice from the Medicines Adverse Reactions Committee, the Minister's delegate has decided to revoke the consent of pholcodine-containing medicines from 12 January 2024.
News and Events
| Date | Type | Title |
|---|---|---|
| 9/11/2023 | Medicines | Medsafe Industry Day - 9 November 2023 |
| 26/9/2023 | Committees | Reclassification of naproxen |
| 26/9/2023 | Committees | Reclassification of paracetamol (liquid formulations) |
| 25/9/2023 | Alert Communication | Consent to distribute pholcodine-containing medicines will be revoked on 12 January 2024 |
| 22/9/2023 | Committees | Agenda for the 71st Medicines Classification Committee meeting - Comments due by 19 Octoberl 2023 |
| 7/9/2023 | Publications | Prescriber Update Vol. 44 No. 3 – September 2023 |
| 4/9/2023 | Alert Communication | Processing of adverse reaction reports received in New Zealand (PDF, 2 pages, 189 KB) |
| 18/8/2023 | Notices | Guidelines on the Regulation of Therapeutic Products in New Zealand - Manufacture of medicines, Edition: 5.1, dated August 2023 |
| 7/8/2023 | Consultation | Medsafe Clozapine Survey 2023 (closes 6 October 2023) |
| 1/8/2023 | Notices | Medsafe performance statistics 2022/2023 |
